Stock comparison
Amgen
AMGN$197.66BHealthcare Market cap, Sector
Camurus AB (publ)
CAMX.ST$36.93BHealthcare Market cap, Sector
Overall winner
Camurus AB (publ)
AMGN 16 CAMX.ST
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
AMGN1wins
6winsCAMX.ST
63C
B78
81B
A91
63C
A94
73B
C65
48D
C63
72B
B77
67C
B77
Side-by-side metrics
| Metric | AMGN | CAMX.ST |
|---|---|---|
| Market cap | Winner: $197.66B | $36.93B |
| P/E (TTM) | Winner: 23.3x | 42.6x |
| EV/EBIT | Winner: 21.3x | 29.5x |
| ROIC (TTM) | 13.85% | 17.17% Winner |
| Gross margin | 71.46% | 93.11% Winner |
| Net margin | 20.95% | 32.47% Winner |
| Revenue CAGR 5y | 9.05% | 33.3% Winner |
| EPS CAGR 5y | 8.5% | 132.79% Winner |
| Debt / Equity | 6.2x | 0.0x Winner |
| Dividend yield | 2.91% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
AMGN leads on
- Market cap$197.66Bvs $36.93B+81%
- P/E (TTM)23.3xvs 42.6x+45%
- EV/EBIT21.3xvs 29.5x+28%
CAMX.ST leads on
- Debt / Equity0.0xvs 6.2x+100%
- EPS CAGR 5y132.79%vs 8.5%+94%
- Revenue CAGR 5y33.3%vs 9.05%+73%
- Net margin32.47%vs 20.95%+35%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.